EZH1 and neoplasm: Previous studies have reported that EZH1 Q571R mutations are associated with increased H3K27me3 levels [10], and that EZH1 mutation–induced H3K27me3 overexpression correlates with tumor aggressiveness and dedifferentiation in thyroid carcinoma [11].